Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,151.20
(
-0.21%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
92.44
(
-4.69%
)
Bitcoin
74,885.15
(
-1.27%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123029
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: palindromy post# 48882

Saturday, 06/23/2007 5:09:36 PM

Saturday, June 23, 2007 5:09:36 PM

Post# of 257648
>For most biologics, the manufacturer would have requested and got a patent term extension under 35 USC 156. The practical limit seems to be 14 yrs from date of approval. This would be an easy way of looking at upcoming expiry I guess.<

That would work if there were no ancillary patents in play. But it’s the ancillary patents that make life so complicated!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today